ChangT.M.S.: Semipermeable aqueous microcapsules (artificial cells): with emphasis on experiments in an extracorporeal shunt system.Trans. Amer. Soc. Art. Int. Organs12, 13, 1966.
2.
ChangT.M.S.: Hemoperfusion alone and in series with ultrafiltration or dialysis for uremia, poisoning and liver failure.Kidney Int.10: S305, 1976.
3.
ChangT.M.S.: Assessments of clinical trials of charcoal hemoperfusion in uremic patients.Clin., Nephrol.11, 111, 1979a.
4.
ChangT.M.S., ChiritoE., BarreP., ColeC., ListerC., ResurrecionE.: Long term Clinical Assessment of combined ACAC hemoperfusion-Ultrafiltration in uremia.Artificial Organs3: 127, 1979b.
5.
De SantoN.G., CapodicasaG., SenatoreR., CicchettiT., CirilloD., DamianoM., TorellaR., GiuglianoD., ImprotaL., GiordanoC.: Glucose utilization from dialysate in patients on continuous ambulatory peritoneal dialysis (CAPD).Int. J. Artif. Organs2: 119, 1979a.
6.
De SantoN.G., CapodicasaG., SenatoreR., CirilloD., DamianoM., GiordanoC.: Stability of peritoneal urea clearances in patients on continuous ambulatory peritoneal dialysis (CAPD).Int. J. Artific. Organs2: 193, 1979b.
7.
GibsonT.P., AtkinsonA.J.Jr.: Effect of changes in intercompartmental rate constants on drug removal during hemoperfusion.J. Pharm. Sci.67: 1178, 1978.
8.
GiordanoC.: Sorbents and their clinical applications.Academic Press, N.Y., 1980.
9.
Nose'Y., MalcheskyP.S.: Sorbents in therapeutic medicine. In: Artificial Organs (Ed. KenediR.M., CoutneyJ.M., GaylorJ.D.S., GilchristT.) Macmillan Press, London and Basingstoke, p. 20, 1977.
10.
OdakaM., KobajashH., TabataY., SomaM.: Three hour maintenance dialysis combined with direct hemoperfusion and hemodialysis.Proc. Europ. Dial. Transplant Assoc.13: 257, 1976.
11.
PopovichR.P., MoncriefJ.W., DecherdJ.F., BomarJ.B., PyleW.K.: The definition of a novel portable/wearable equilibrium peritoneal dialysis technique (abstr.).Trans. Am. Soc. Artif. Organs5: 64, 1976.
PopovichR.P., HiattM.P., MoncriefJ.W., PyleW.K.: Mathematical modeling and minimum treatment requirements in peritoneal dialysis. In: Uremia (Ed. GiordanoC., and FriedmanEli A.) Wichtig Editore, Milano, Italy. p. 214, 1981.
14.
StefoniS., ColiL., FeliciangeliG., BaldratiL., BonominiV.: Regular hemoperfusion in regular dialysis treatment.A long term study. Int. J. Art. Organs3: 348, 1980.
15.
StefoniS., FeliciangeliG., ColiL., ScolariM.P., BonominiV.: Combined hemodialysis-hemoperfusion treatment reduces the time of substitutive therapy in chronic uremia.Int. J. Artif. Organs4: 186, 1981.
WinchesterJ.F., ApiligaM.T., KennedyA.C.: Short term evaluation of charcoal hemoperfusion combined with dialysis in uremic patientsKidney International12: S315, 1976.
18.
WinchesterJ.F.: Clinical application of hemoperfusion in uremia.Artif. Organs, (Ed. KenediR.M., CourtneyJ.M., GaylorJ.D.S., GilchristT.) Macmillan Press, London and Basingstoke188, 1977.
19.
YatzidisH.: A convenient hemoperfusion micro-apparatus over charcoal for treatment of endogenous and exogenous intoxications: its use as an artificial kidney.Proc. Eur. Dial. Transplant. Assoc.1: 83, 1964.
